Ataxias: hunting down the genetic causes of these devastating disorders of balance and coordination
First published on 21 November 2012
Updated on 24 October 2017
What did the project achieve?
“We’ve successfully identified new genetic causes of some rare, disabling disorders called ataxias,” says Dr Andrea Nemeth of the University of Oxford.
Ataxia is a term for a group of disorders that affect balance and coordination. Some children with ataxia find their symptoms remain stable, although they persist lifelong, but others find their symptoms deteriorate over time.
“It’s really important to have identified more genes associated with ataxia, because this will improve genetic testing, giving more children and their families an explanation of what’s causing their condition and better information about what the future might hold for them,” says Dr Nemeth.”
“Our work has already benefitted families who took part in our research, for example by providing reassurance, in some cases, that a child’s condition will not deteriorate and helping parents to make decisions about having more children,” adds Dr Nemeth. “Better genetic tests for ataxia could also spare children from going through more traumatic tests, such as lumbar punctures and MRI scans. Excitingly we have identified at least one ataxia which might be amenable to treatment and we are now investigating this further.”
Dr Nemeth concludes: “The funding for this project has been absolutely crucial for expanding research into the genetic causes of childhood ataxias and we plan to continue our important work in the future.”
This research was completed on 25 April 2016
Children with ataxia have problems with balance and coordination, which can rob them of their ability to walk and make everyday activities difficult. It is often uncertain exactly what a child’s future holds – sadly for some children their disorder is progressive and life limiting, whereas other children find their condition remains constant throughout life. Dr Andrea Nemeth, of the University of Oxford, is searching for the genetic causes of ataxia, to give families a better understanding of why they’ve been affected and what the future holds for them.
What is the problem and who does it affect?
No-one knows exactly how many children in the UK are suffering from ataxia. It’s thought to be several thousand.1,2 We do know that ataxia occurs in all age groups – affecting babies, children, teenagers and adults alike.
“Ataxias are actually a group of different disorders, all characterised by loss of balance and coordination,” explains Dr Nemeth. Sadly, ataxias are often progressive. Typically, children slowly lose their ability to walk, and may eventually need to use a wheelchair, their speech can become slurred and everyday tasks – even just reaching out to have a drink of water – can become difficult.
There is no cure for ataxia, although treatment can relieve some of the symptoms associated with specific conditions.
“Several things can cause ataxia, including infection or illness around the time of birth, tumours, exposure to drugs or genetic factors,” says Dr Nemeth. “However, when a child is first diagnosed, it’s often difficult to find out why they’ve developed the condition.”
All too often, important questions remain unanswered: “If we don’t know what’s causing a child’s ataxia, it’s hard to tell how best to treat him, or her, and difficult to predict whether the illness will progress. This uncertainty causes significant anxiety for children and their families.”
What is the project trying to achieve?
“We strongly suspect that many ataxias are caused by genetic factors, even those previously thought to be non-genetic” explains Dr Nemeth. “Disease-causing changes in around 60 human genes have already been linked to ataxia. However, our research shows many children who have inherited the condition do not have changes in these genes. So we are looking for disease-causing changes in other genes and trying to find out how they work. We will initially investigate 20 families, but aim to increase this number as more families are referred to us.”
If successful, Dr Nemeth’s work could lead to a range of benefits. “We hope that our research will lead to new genetic tests for ataxia, which could spare children from going through more traumatic tests, such as lumbar punctures and MRI scans. It could mean children receive a definitive diagnosis much earlier, along with important information about their outlook for the future. One day, our work might also lead to better treatments.”
What are the researchers’ credentials?
Dr Nemeth’s determination to improve the lives of people with ataxias stems from early experiences treating children whose condition remained unexplained. Nearly twenty years down the line, she has gathered a large collection of DNA samples from children with ataxia and has already identified one new genetic cause of the condition.
|Project Leader||Dr A H Nemeth|
|Location||Nuffield Department of Clinical Neurosciences, University of Oxford and Oxford University Hospitals NHS Trust|
|Grant awarded||21 August 2012|
|Start date||15 July 2013|
|End date||25 April 2016|
|Acknowledgements||This project is funded by a generous donation from The Henry Smith Charity|
We do not provide medical advice. If you would like more information about a condition or would like to talk to someone about your health, contact NHS Choices or speak to your GP. Please see our useful links page for some links to health information, organisations we are working with and other useful organisations. We hope you will find these useful. We are not responsible for the content of any of these sites.
- Millie Mae’s World. Raising awareness and funds for Ataxia UK with smiles. 2020Vision – aiming for a cure for ataxia. How many people have ataxia? http://milliemaesworld.co.uk/millie/category/latest-ataxia-news/ Website accessed 12 October 2012.
- Anheim M et al. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics 2010; 11(1): 1-12.